Press Releases
U.S. FDA Grants Priority Review to Janssen’s New Drug Application for Chewable Mebendazole Tablets
Janssen Pharmaceuticals, Inc announced that the U.S. FDA has granted Priority Review designation for the NDA for a 500mg chewable tablet formulation of mebendazole....
Press Releases
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Amgen and Daiichi Sankyo Company, Limited announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal includes several biosimilars...
Press Releases
Sandoz Biosimilar Etanercept Recommended By US FDA For Approval To Treat Multiple Inflammatory Diseases
Sandoz, a Novartis division and leader in biosimilars, announced that the US FDA Advisory Committee recommended approval of its proposed biosimilar etanercept. The committee...
News
Lilly And Boehringer Ingelheim Announce Clinical Trial Collaboration In Metastatic Breast Cancer
Eli Lilly and Company and Boehringer Ingelheim announced a new collaboration on a Phase 1b study that will evaluate the safety and tolerability of...
News
Bayer and X-Chem Expand Drug Discovery Collaboration to Discover Novel Medicines
Bayer and X-Chem, Inc., a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule...
Industry Reports
Questex Acquires ExL Events
Questex, a leading global business information and events company announced it has acquired ExL Events, Inc., expanding Questex's presence in the global pharmaceutical, life...
Press Releases
Mylan NV Launches Generic Temodar Capsules
Mylan N.V. announced the U.S. launch of Temozolomide Capsules, 5 mg, 20 mg, 100 mg, 140 mg, 180 mg and 250 mg, which is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read